Quiz: Test Your Knowledge of the Affordable Care Act
Take this ten-question quiz to see how much you know about how the ACA affects health insurance coverage and costs as well as who is eligible for financial assistance
View the Latest: Feature
Filter
-
-
ACIP Vote Drives Online Engagement About Hepatitis B Vaccine, And Posts Claim a VAERS “Cover-Up” of COVID-19 Vaccine Deaths — The Monitor
FeatureNearly two weeks after a CDC advisory panel voted to end the recommendation for newborn hepatitis B vaccination, conversations about vaccination schedules and parental choice remain elevated. Meanwhile, narratives about an FDA memo alleging COVID-19 vaccines caused 10 pediatric deaths have shifted toward claims of a government cover-up.
-
Key Data on Health and Health Care by Race and Ethnicity
Issue BriefThis analysis examines how people of color fare compared to White people across 64 measures of health, health care, and social determinants of health using the most recent data available from federal surveys and administrative sets as well as the 2023 KFF Survey on Racism, Discrimination, and Health.
-
CDC Vaccine Panel Ends Universal Hepatitis B Recommendation and Reviews Aluminum in Vaccines, Plus Public Awareness of Mifepristone Safety — The Monitor
FeatureThis volume shares updates from the most recent CDC advisory panel meeting, changes to the CDC webpage on autism and vaccines, and polling on trust in news organizations. Additionally, it shares recent developments in AI and social media policy and new KFF poll findings about perceptions of mifepristone’s safety and prevalence.
-
Fake AI-Generated Videos Perpetuate Stereotypes About SNAP Recipients, And New KFF Poll Looks at Belief in the False Claim That Undocumented Immigrants Are Eligible for ACA Coverage — The Monitor
FeatureThis volume examines how AI-generated videos contributed to false narratives about SNAP recipients; findings from KFF’s Health Tracking Poll on beliefs about undocumented immigrants’ ACA eligibility; how a new film amplifies false vaccine claims; Louisiana’s delayed whooping cough response; medical education efforts to address shame; and teens’ distrust of news media.
-
Medicare Advantage Glossary
FeatureThis glossary serves as a guide to the sometimes arcane terms that inhabit the world of Medicare Advantage, the private plan alternative to traditional Medicare.
-
Social Media Content Moderation Policies and False Claims that COVID-19 Vaccines Cause Cancer — The Monitor
FeatureThis volume examines recent social media and AI policy changes; conflicting studies on COVID-19 vaccines and cancer; ACOG guidance on contraceptive misinformation; an alternative to the CDC’s MMWR; the Texas AG’s Tylenol lawsuit; and findings from a recent KFF Tracking Poll on trust in health care apps and websites that use AI.
-
Calculator: ACA Enhanced Premium Tax Credit
FeatureThe ACA's enhanced premium tax credits expired at the end of 2025. This calculator estimates how much out-of-pocket premium payments would increase for families without the enhanced credits. The projected premium increases are estimated based on family income, zip code, size, ages, and 2026 ACA Marketplace premiums.
-
KFF/Washington Post Poll Looks at Parents’ Trust in Children’s Health Content on Social Media, And Unfounded Claims About Abortion Pill Safety Follow FDA Approval of Generic Version – The Monitor
FeatureThis volume shares findings from the KFF/The Washington Post Survey of Parents about exposure to and trust in children’s health content on social media, along with misleading claims following the approval of a generic version of mifepristone, reports of autism possibly being added to the Vaccine Injury Compensation Program, and patients using AI chatbots to interpret lab results.
-
2025 Employer Health Benefits Survey
ReportThis annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, worker contributions, cost-sharing provisions, offer rates, and more. This year's report also looks at how employers are approaching coverage of GLP-1 drugs for weight loss, including their concerns about utilization and cost.